Acquired by Merck & Co.
Therapeutics based on RNA interference (RNAi).
San Diego, CA
Investors 1
| Date | Name | Website |
| - | New Leaf V... | nlvpartner... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 03.10.2008 | Intradigm lands $18.5M to advance oncology treatment | Intradigm, a biotech company that develops RNA interference treatments for cancer, announced today t... | venturebea... |
| 12.07.2007 | Roundup: Biogenerics bill in limbo, clashing data on health ... | House-Senate confrontation set over biogenerics — Late last month, a key group of senators reached a... | venturebea... |
| 10.07.2007 | RNAi developer Protiva raises $3.3M | Protiva, a Vancouver, B.C.-based developer of drugs based on the new technology of RNA interference,... | venturebea... |